Financials

  • Market Capitalization 557.93 M
  • Employee 674
  • Founded 2013
  • CEO Thomas Lingelbach
  • Website www.valneva.com
  • Headquarter France
  • FIGI BBG00ZZPBH08
  • Industry 生物技术

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2830
SPRY
ARS Pharmaceuticals, Inc. - Common Stock
5.89 USD-2.32%+9.07%+1.55%-36.05%585.74 M USD
2831
MPLT
MapLight Therapeutics, Inc. - Common Stock
12.60 USD+0.48%+12.40%-16.94%-33.68%584.36 M USD
2856
CAPR
Capricor Therapeutics, Inc. - Common Stock
9.59 USD-4.67%+19.58%+212.38%+53.19%557.55 M USD
2860
DRUG
Bright Minds Biosciences Inc. - common stock
72.81 USD-2.32%-5.50%+1.70%+85.83%555.96 M USD

Valneva SE - American Depositary Shares

Valneva SE 是一家注册于法国圣埃尔布兰的专科疫苗公司,致力于传染病疫苗的研发、生产和商业化。该公司在苏格兰利文斯顿、瑞典索尔纳和奥地利维也纳设有生产基地,并在法国、加拿大和美国设有其他办事处。

新闻